a million and one different vendors. Unless they test everyone, the findings are meaningless.
For the remaining players it's going to be tough. It's tough already.
The market share for generics, which is already 54 percent [of prescriptions] should increase significantly,
The psychology of it -- $100 -- it seems like a lot. That's a nice problem to have. So few companies are doing very, very well.
We continue to believe that NRP104 has a best-in-class clinical profile and blockbuster market potential, given its improved safety profile compared to other stimulants.
This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.
This website focuses on proverbs in the Swedish, Danish and Norwegian languages, and some parts including the links below have not been translated to English. They are mainly FAQs, various information and webpages for improving the collection.